Plasma-mediated vascular dysfunction in the reduced uterine perfusion pressure model of preeclampsia: a microvascular characterization.
Affiliation
Anu Research Centre, Department of Obstetrics and Gynaecology, University College, Cork, Cork University Maternity Hospital, Wilton, Cork, Ireland. S.Walsh@ucc.ieIssue Date
2012-01-31T16:42:27ZMeSH
Analysis of VarianceAnimals
Blood Pressure Determination
Disease Models, Animal
Endothelium, Vascular/physiology
Female
Microcirculation/drug effects/*physiology
NG-Nitroarginine Methyl Ester/*pharmacology
Nitric Oxide/*metabolism
Perfusion/methods
Placenta/blood supply
Pre-Eclampsia/*physiopathology
Pregnancy
Pressure
Probability
Random Allocation
Rats
Rats, Sprague-Dawley
Risk Factors
Uterus/*blood supply
Vasoconstriction/drug effects/physiology
Vasodilation/drug effects/physiology
Metadata
Show full item recordCitation
Hypertension. 2009 Aug;54(2):345-51. Epub 2009 Jun 29.Journal
HypertensionDOI
10.1161/HYPERTENSIONAHA.109.132191PubMed ID
19564546Abstract
Preeclampsia is associated with widespread maternal vascular dysfunction, which is thought to be mediated by circulating factor(s). The aim of the study was to characterize vascular function in the reduced uterine perfusion pressure (RUPP) rat model of preeclampsia and to investigate the role of plasma factors in mediating any observed changes in vascular reactivity. Mean arterial blood pressure and vascular function were measured in RUPP and control rats. Mesenteric vessels from both virgin and pregnant rats were exposed for 1 hour or overnight to plasma from both RUPP and control rats and their vascular function assessed. RUPP rats were characterized by severe hypertension, restricted fetal growth, and reduced placental weight (P<0.001). Vasorelaxation was impaired in resistance vessels from RUPP compared with control rats (acetylcholine: R(max) 70+/-3 versus 92+/-1 [NP] and 93+/-3% [sham], P<0.01; bradykinin: 40+/-2 versus 62+/-2 [NP] and 59+/-4% [sham], P<0.001). Incubation of vessels from pregnant (but not virgin) animals with RUPP plasma overnight resulted in an attenuation of vasorelaxant responses (acetylcholine: 63+/-7 versus 86+/-2%, P<0.05; bradykinin: 35+/-5 versus 55+/-6%, P<0.001). The residual relaxant response in RUPP plasma-treated vessels was not further attenuated after treatment with N(omega)-nitro-l-arginine methyl ester (acetylcholine: 57+/-7 versus 63+/-7%, ns; bradykinin: 37+/-5 versus 35+/-5%, ns). The RUPP rat model is characterized by an impaired response to vasodilators which may be attributable to one or more circulating factors. This plasma-mediated endothelial dysfunction appears to be a pregnancy-dependent effect. Furthermore, nitric oxide-mediated vasorelaxation appears to be absent in RUPP plasma-treated vessels.Language
engISSN
1524-4563 (Electronic)0194-911X (Linking)
ae974a485f413a2113503eed53cd6c53
10.1161/HYPERTENSIONAHA.109.132191
Scopus Count
Collections
Related articles
- NLRP3 inhibition improves maternal hypertension, inflammation, and vascular dysfunction in response to placental ischemia.
- Authors: Wang X, Travis OK, Shields CA, Tardo GA, Giachelli C, Nutter CW, Glenn HL, Cooper OG, Davis T, Thomas R, Williams JM, Cornelius DC
- Issue date: 2023 Apr 1
- Comparison of different modified operations in the reduced uteroplacental perfusion pressure rat model of preeclampsia.
- Authors: Shi M, Yang X, Sun L, Ding Y, Huang Z, Zhang P, Yang X, Li R, Wang G
- Issue date: 2023 Mar
- Inhibition of Angiotensin II Type 1 Receptor Agonistic Autoantibodies by Direct Binding Does Not Impact RUPP Offspring Birth Weight and Blood Pressure at Adulthood.
- Authors: Solise D, Campbell N, Ashraf U, Herrock O, Crudup B, Mallette J, Willis A, Rawls AZ, Turner T, Cockrell K, Zheng B, Deer E, Amaral L, Alexander BT, Lamarca B
- Issue date: 2023 Mar 27